Table 2 Comparison of clinicopathological features between patients with cervical oesophageal cancer and patients with thoracic or abdominal oesophageal cancer who underwent surgery.
From: Clinicopathological features and surgical treatment of cervical oesophageal cancer
| Ā | CEC | T/A oesophageal cancer | P-value |
|---|---|---|---|
Gender | Ā | Ā | 1.000 |
Ā Ā Male | 21 (75.0%) | 2964 (75.0%) | Ā |
Ā Ā Female | 7 (25.0%) | 986 (25.0%) | Ā |
Age(years) | Ā | Ā | 0.697 |
Ā Ā ā¤60 | 19 (67.9%) | 2487 (63.0%) | Ā |
Ā Ā >60 | 9 (32.1%) | 1463 (37.0%) | Ā |
Tumour length | Ā | Ā | 0.079 |
Ā Ā ā¤4ācm | 15 (53.6%) | 1463 (37.0%) | Ā |
Ā Ā >4ācm | 13 (46.4%) | 2487 (63.0%) | Ā |
Histology | Ā | Ā | 1.000 |
Ā Ā SCC | 27 (96.4%) | 3804 (96.3%) | Ā |
Ā Ā Others | 1 (3.6%) | 146 (3.7%) | Ā |
Tumour cell differentiation | Ā | Ā | 0.471 |
Ā Ā Well | 11 (39.3%) | 1321 (33.4%) | Ā |
Ā Ā Moderate | 12 (42.9%) | 2129 (53.9%) | Ā |
Ā Ā Poor | 5 (17.9%) | 500 (12.7%) | Ā |
pT category | Ā | Ā | 1.000 |
Ā Ā pT0ā2 | 7 (25.0%) | 1069 (27.1%) | Ā |
Ā Ā pT3ā4 | 21 (75.0%) | 2881 (72.9%) | Ā |
pN category | Ā | Ā | 0.850 |
Ā Ā pN0 | 14 (50.0%) | 2092 (53.0%) | Ā |
Ā Ā pN1 | 14 (50.0%) | 1858 (47.0%) | Ā |
pTNM stage | Ā | Ā | 0.187 |
Ā Ā 0āII | 10 (35.7%) | 1934 (49.0%) | Ā |
Ā Ā IIIāIV | 18 (64.3%) | 2016 (51.0%) | Ā |
Resection margin | Ā | Ā | 0.763 |
Ā Ā R0 | 26 (92.9%) | 3509 (88.8%) | Ā |
Ā Ā R 1ā2 | 2 (7.1%) | 441 (11.2%) | Ā |
Preoperative therapy | Ā | Ā | <0.001 |
Ā Ā None | 18 (64.3%) | 3559 (90.1%) | Ā |
Ā Ā Chemotherapy | 0 (0%) | 7 (0.2%) | Ā |
Ā Ā Radiotherapy | 2 (7.1) | 193 (4.9%) | Ā |
Ā Ā Chemoradiotherapy | 8 (28.6) | 191 (4.9%) | Ā |
